Insider Trading February 9, 2026

Maximus CFO Acquires 1,000 Shares; Firm Posts Mixed Q1 Fiscal 2026 Results

David Mutryn increases direct stake as company posts EPS beat but revenue shortfall in Q1 FY2026

By Priya Menon MMS
Maximus CFO Acquires 1,000 Shares; Firm Posts Mixed Q1 Fiscal 2026 Results
MMS

Maximus, Inc. Chief Financial Officer David Mutryn purchased 1,000 shares of company stock on February 9, 2026, at $75.625 per share, bringing his direct holdings to 40,036.754 shares. The transaction was disclosed in an SEC Form 4. Separately, Maximus reported fiscal 2026 first-quarter results that beat on earnings per share but missed revenue expectations.

Key Points

  • Maximus CFO David Mutryn bought 1,000 shares on February 9, 2026, at $75.625 per share, totaling $75,625.
  • After the purchase Mutryn directly owns 40,036.754 shares; the transaction was reported on an SEC Form 4.
  • Maximus’ Q1 FY2026 results showed EPS of $1.85 (5.71% above estimates) and revenue of $1.35 billion (6.25% below expectations).

David Mutryn, the Chief Financial Officer of Maximus, Inc. (NASDAQ:MMS), executed a personal purchase of 1,000 shares of the company’s common stock on February 9, 2026, at a per-share price of $75.625. The total consideration for the acquisition was $75,625. The purchase was disclosed formally to the Securities and Exchange Commission via a Form 4 filing.

Following the transaction, Mutryn’s direct ownership of Maximus common stock stands at 40,036.754 shares. The Form 4 filing records the change in beneficial ownership and provides the market and compliance community with an official trace of the insider trade.


In parallel with the insider transaction, Maximus released results for the first quarter of fiscal 2026. The company reported diluted earnings per share of $1.85, exceeding the analyst consensus estimate of $1.75. That outcome represents a 5.71% positive surprise versus expectations.

On the top line, Maximus reported revenue of $1.35 billion for the quarter, falling short of the anticipated $1.44 billion. The revenue shortfall equates to a 6.25% miss relative to the consensus forecast. The juxtaposition of an EPS beat and a revenue miss produced a mixed financial picture for the period.

The company’s published results did not include any updates regarding mergers or acquisitions. Likewise, there were no reported analyst upgrades or downgrades tied to the announcement.


These items - the CFO’s open-market purchase and the mixed quarterly results - were formally recorded in public filings and earnings disclosures. The trade and the quarterly metrics offer discrete datapoints for investors and market watchers assessing insider sentiment and operating performance for Maximus in fiscal 2026.

Where details were limited in the disclosures, the record reflects only the transaction specifics, the SEC filing, and the headline quarterly figures. No additional corporate actions or analyst movement were reported alongside these developments.

Risks

  • Revenue came in below consensus, indicating uncertainty in near-term sales performance which could affect valuation - impacts revenue-driven sectors and investor sentiment.
  • The mixed earnings signal (EPS beat with revenue miss) creates ambiguity for analysts and investors assessing forward guidance and forecasts - impacts equity analysts and market participants focused on public contractors.
  • Limited disclosures beyond the Form 4 and the headline quarterly figures restrict visibility into management’s broader view and potential strategic moves - impacts transparency for shareholders and market researchers.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026